{"database": "lobbying", "table": "lobbying_activities", "rows": [[2866189, "f3d34521-eb93-47bf-8b7d-78f8c8fafbcd", "Q3", "TIBER CREEK GROUP", 20744, "TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF ELI LILLY AND COMPANY)", 2022, "third_quarter", "CPT", "H.R. 2891 - Preserve Access to Affordable Generics and Biosimilars Act.", "HOUSE OF REPRESENTATIVES,SENATE", 80000, null, 0, 0, "2022-10-15T11:08:04-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2866189"], "units": {}, "query_ms": 18.05359509307891, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}